Linear Accelerators for Radiation Market: Trends, Growth Opportunities and Industry Statistics Till 2030
Ngày đăng: 18-08-2023 |
Ngày cập nhật: 18-08-2023
The Linear Accelerators for Radiation Market used in radiation therapy is anticipated to witness a consistent revenue compound annual growth rate (CAGR) of 5.1% from 2022 to 2030. Several pivotal factors, including an escalation in cancer prevalence, surging demand for radiotherapy treatment, and remarkable advancements in linear accelerator technology, are propelling the expansion of this market.
In recent times, the global tally of cancer cases has experienced a marked upsurge, a trend expected to persist and intensify in the upcoming years. According to the World Health Organization (WHO), the number of individuals afflicted by cancer is projected to soar by 70% over the next twenty years. This demographic shift constitutes a crucial driver underpinning the growth of the linear accelerators for radiation market.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5149
The mounting demand for radiotherapy, as an efficacious modality in cancer treatment, stands as another catalyst propelling market expansion. Radiotherapy harnesses high-energy x-rays or electrons to annihilate cancer cells and reduce tumor sizes. The growing preference for radiotherapy will be instrumental in fueling market growth throughout the forecast period.
Furthermore, the evolution of linear accelerator technology is imparting momentum to market growth. Recent years have witnessed a substantial transformation in linear accelerator capabilities due to breakthrough technologies such as intensity-modulated radiotherapy, image-guided radiotherapy, and proton therapy. These innovations confer numerous advantages over conventional linear accelerators and are anticipated to foster market expansion over the forecast horizon.
Nevertheless, market growth is anticipated to be curtailed by factors such as the elevated cost of treatment and the potential side effects associated with radiation therapy.
Segment Analysis: The Linear Accelerators for Radiation Market is categorized based on product type, technology, end-user, and geography.
In terms of product type, the market is segmented into electron linear accelerators and x-ray linear accelerators. The electron linear accelerator segment is set to exhibit robust growth during the forecast period, owing to the escalating preference for this variant over x-ray linear accelerators. Electron linear accelerators offer distinct advantages such as reduced skin toxicity, shorter treatment durations, and heightened tumor control rates.
Regarding technology, the market is divided into photon therapy and electron therapy. The photon therapy segment is poised to dominate the market due to its growing preference. Photon therapy employs high-energy x-rays to obliterate cancer cells and reduce tumor sizes, constituting the most prevalent form of radiation therapy for cancer treatment. Conversely, the electron therapy segment is projected to register a higher revenue CAGR across the forecast duration, primarily driven by the increasing favorability towards this therapy. Electron therapy employs high-energy electrons to annihilate cancer cells and reduce tumor sizes, offering advantages such as reduced skin toxicity and shorter treatment durations compared to photon therapy.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/5149
Based on end-user, the market is segmented into hospitals, cancer research centers, and academic & research institutes. The hospital segment is poised to dominate the market due to the escalating caseload of cancer patients and the growing inclination towards radiotherapy. Furthermore, cancer research centers are expected to exhibit a notable revenue CAGR during the forecast period, attributable to increased government funding for cancer research and clinical trials.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America is projected to maintain dominance in the global linear accelerators for radiation market during the forecast period. This is ascribed to the availability of reimbursement policies and the growing prevalence of cancer cases in the region. However, the Asia Pacific region is forecasted to experience the highest revenue CAGR over the forecast horizon, fueled by the rising cancer incidence, government funding for cancer research, and expanding healthcare infrastructure.
Competitive Analysis: Prominent players in this market encompass Varian Medical Systems (US), Elekta AB (Sweden), Accuray Incorporated (US), Hitachi, Ltd. (Japan), IBA Worldwide (Belgium), Mevion Medical Systems (US), Nucletron B.V. (Netherlands), Proton Therapy Center Amsterdam (Netherlands), Provident Health Partners (US), and RaySearch Laboratories AB (Sweden).
To augment their market share, these entities are deploying various strategies including new product launches, partnerships, collaborations, and acquisitions.
Recent Developments: In 2020, Accuray Incorporated unveiled the Radixact TomoTherapy System, a cutting-edge radiation therapy platform designed to deliver precision-focused, conformal doses to tumors while safeguarding surrounding healthy tissue. In 2019, IBA Worldwide completed the acquisition of Mayo Clinic’s Proton Therapy Program, bolstering its presence in the US proton therapy market.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5149
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Organ Preservation Market
Contrast Media Market
Diagnostic Imaging Services Market
Electronic Bone Growth Stimulators (BGS) Market
Disposable Surgical Gloves Market
Healthcare Personal Protective Equipment (PPE) Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
In recent times, the global tally of cancer cases has experienced a marked upsurge, a trend expected to persist and intensify in the upcoming years. According to the World Health Organization (WHO), the number of individuals afflicted by cancer is projected to soar by 70% over the next twenty years. This demographic shift constitutes a crucial driver underpinning the growth of the linear accelerators for radiation market.
Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5149
The mounting demand for radiotherapy, as an efficacious modality in cancer treatment, stands as another catalyst propelling market expansion. Radiotherapy harnesses high-energy x-rays or electrons to annihilate cancer cells and reduce tumor sizes. The growing preference for radiotherapy will be instrumental in fueling market growth throughout the forecast period.
Furthermore, the evolution of linear accelerator technology is imparting momentum to market growth. Recent years have witnessed a substantial transformation in linear accelerator capabilities due to breakthrough technologies such as intensity-modulated radiotherapy, image-guided radiotherapy, and proton therapy. These innovations confer numerous advantages over conventional linear accelerators and are anticipated to foster market expansion over the forecast horizon.
Nevertheless, market growth is anticipated to be curtailed by factors such as the elevated cost of treatment and the potential side effects associated with radiation therapy.
Segment Analysis: The Linear Accelerators for Radiation Market is categorized based on product type, technology, end-user, and geography.
In terms of product type, the market is segmented into electron linear accelerators and x-ray linear accelerators. The electron linear accelerator segment is set to exhibit robust growth during the forecast period, owing to the escalating preference for this variant over x-ray linear accelerators. Electron linear accelerators offer distinct advantages such as reduced skin toxicity, shorter treatment durations, and heightened tumor control rates.
Regarding technology, the market is divided into photon therapy and electron therapy. The photon therapy segment is poised to dominate the market due to its growing preference. Photon therapy employs high-energy x-rays to obliterate cancer cells and reduce tumor sizes, constituting the most prevalent form of radiation therapy for cancer treatment. Conversely, the electron therapy segment is projected to register a higher revenue CAGR across the forecast duration, primarily driven by the increasing favorability towards this therapy. Electron therapy employs high-energy electrons to annihilate cancer cells and reduce tumor sizes, offering advantages such as reduced skin toxicity and shorter treatment durations compared to photon therapy.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/5149
Based on end-user, the market is segmented into hospitals, cancer research centers, and academic & research institutes. The hospital segment is poised to dominate the market due to the escalating caseload of cancer patients and the growing inclination towards radiotherapy. Furthermore, cancer research centers are expected to exhibit a notable revenue CAGR during the forecast period, attributable to increased government funding for cancer research and clinical trials.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America is projected to maintain dominance in the global linear accelerators for radiation market during the forecast period. This is ascribed to the availability of reimbursement policies and the growing prevalence of cancer cases in the region. However, the Asia Pacific region is forecasted to experience the highest revenue CAGR over the forecast horizon, fueled by the rising cancer incidence, government funding for cancer research, and expanding healthcare infrastructure.
Competitive Analysis: Prominent players in this market encompass Varian Medical Systems (US), Elekta AB (Sweden), Accuray Incorporated (US), Hitachi, Ltd. (Japan), IBA Worldwide (Belgium), Mevion Medical Systems (US), Nucletron B.V. (Netherlands), Proton Therapy Center Amsterdam (Netherlands), Provident Health Partners (US), and RaySearch Laboratories AB (Sweden).
To augment their market share, these entities are deploying various strategies including new product launches, partnerships, collaborations, and acquisitions.
Recent Developments: In 2020, Accuray Incorporated unveiled the Radixact TomoTherapy System, a cutting-edge radiation therapy platform designed to deliver precision-focused, conformal doses to tumors while safeguarding surrounding healthy tissue. In 2019, IBA Worldwide completed the acquisition of Mayo Clinic’s Proton Therapy Program, bolstering its presence in the US proton therapy market.
Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/5149
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports:
Organ Preservation Market
Contrast Media Market
Diagnostic Imaging Services Market
Electronic Bone Growth Stimulators (BGS) Market
Disposable Surgical Gloves Market
Healthcare Personal Protective Equipment (PPE) Market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
